b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29246367</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>24</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>01</Month>\n            <Day>24</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1578-2190</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>109</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Apr</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Actas dermo-sifiliograficas</Title>\n                <ISOAbbreviation>Actas Dermosifiliogr</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>248-253</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0001-7310(17)30601-4</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ad.2017.10.008</ELocationID>\n            <Abstract>\n                <AbstractText Label="INTRODUCTION AND OBJECTIVES" NlmCategory="OBJECTIVE">Imiquimod is an excellent option for patients with actinic keratosis, although its use may be limited by the long course of treatment required (4 weeks) and the likelihood of local skin reactions. The objectives of the present study were to demonstrate the effectiveness of a 12-day course of imiquimod 5% for the treatment of actinic keratosis and to examine the association between treatment effectiveness and severity of local reactions.</AbstractText>\n                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We included patients with at least 8 actinic keratoses treated with imiquimod 5% cream for 12 consecutive days. Local reactions were classified as mild, moderate, or severe. The statistical analysis of the association between local reactions and clinical response was based on the Pearson \xcf\x87<sup>2</sup> test and the Spearman rank correlation test.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-five patients completed the study. Complete response was recorded in 52.3% and partial response in 75.4%. We found a statistically significant association between severity of the local reaction and response to treatment in both the Pearson \xcf\x87<sup>2</sup> test and the Spearman rank correlation test.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A 12-day course of imiquimod 5% proved effective for the treatment of actinic keratosis. Severity of local reactions during treatment was correlated with clinical response.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2017 AEDV. Publicado por Elsevier Espa\xc3\xb1a, S.L.U. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Serra-Guill\xc3\xa9n</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a; Departamento de Piel y \xc3\x93rganos de los Sentidos, Facultad de Medicina, Universidad CEU Cardenal Herrera, Valencia, Espa\xc3\xb1a. Electronic address: cserraguillen@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nagore</LastName>\n                    <ForeName>E</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a; Departamento de Dermatolog\xc3\xada, Facultad de Medicina, Universidad Cat\xc3\xb3lica de Valencia, Valencia, Espa\xc3\xb1a.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Llombart</LastName>\n                    <ForeName>B</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sanmart\xc3\xadn</LastName>\n                    <ForeName>O</ForeName>\n                    <Initials>O</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a; Departamento de Dermatolog\xc3\xada, Facultad de Medicina, Universidad Cat\xc3\xb3lica de Valencia, Valencia, Espa\xc3\xb1a.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Requena</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Calomarde</LastName>\n                    <ForeName>L</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Guill\xc3\xa9n</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Servicio de Dermatolog\xc3\xada, Instituto Valenciano de Oncolog\xc3\xada, Valencia, Espa\xc3\xb1a; Departamento de Piel y \xc3\x93rganos de los Sentidos, Facultad de Medicina, Universidad CEU Cardenal Herrera, Valencia, Espa\xc3\xb1a.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <Language>spa</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016430">Clinical Trial</PublicationType>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <VernacularTitle>Tratamiento con imiquimod al 5% durante 12 d\xc3\xadas para las queratosis act\xc3\xadnicas: estudio de la eficacia y la reacci\xc3\xb3n local.</VernacularTitle>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>12</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Spain</Country>\n            <MedlineTA>Actas Dermosifiliogr</MedlineTA>\n            <NlmUniqueID>0373062</NlmUniqueID>\n            <ISSNLinking>0001-7310</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007369">Interferon Inducers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>P1QW714R7M</RegistryNumber>\n                <NameOfSubstance UI="D000077271">Imiquimod</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <CommentsCorrectionsList>\n            <CommentsCorrections RefType="CommentIn">\n                <RefSource>Actas Dermosifiliogr. 2018 Apr;109(3):200</RefSource>\n                <PMID Version="1">29217226</PMID>\n            </CommentsCorrections>\n        </CommentsCorrectionsList>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077271" MajorTopicYN="N">Imiquimod</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007369" MajorTopicYN="N">Interferon Inducers</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055623" MajorTopicYN="N">Keratosis, Actinic</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Actinic keratosis</Keyword>\n            <Keyword MajorTopicYN="N">Imiquimod</Keyword>\n            <Keyword MajorTopicYN="N">Local reaction</Keyword>\n            <Keyword MajorTopicYN="N">Queratosis act\xc3\xadnicas</Keyword>\n            <Keyword MajorTopicYN="N">Reacci\xc3\xb3n local</Keyword>\n            <Keyword MajorTopicYN="N">Tratamiento</Keyword>\n            <Keyword MajorTopicYN="N">Treatment</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>07</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>09</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29246367</ArticleId>\n            <ArticleId IdType="pii">S0001-7310(17)30601-4</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ad.2017.10.008</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'